Filter
2650
Text search:
TB
drugs
Featured
Recommendations
240
New Publications
804
Language
Document type
No document type
1836
Guidelines
290
Studies & Reports
285
Manuals
76
Strategic & Response Plan
70
Training Material
33
Fact sheets
32
Situation Updates
13
Infographics
8
Resource Platforms
5
Brochures
1
Online Courses
1
Countries / Regions
India
183
Kenya
104
South Africa
92
Ethiopia
67
Western and Central Europe
65
Zambia
64
Tanzania
63
Uganda
62
Nepal
59
Global
59
Nigeria
56
Malawi
53
Sierra Leone
48
Rwanda
44
Liberia
43
Eastern Europe
43
Africa
39
Bangladesh
37
Namibia
37
Ghana
35
Myanmar / Burma
34
Ukraine
33
Lesotho
33
Philippines
29
Asia
28
Cambodia
26
Indonesia
24
Zimbabwe
23
Latin America and the Carribbean
21
Botswana
20
South–East Asia Region
20
Russia
14
Senegal
13
Mozambique
13
Eswatini/ Swaziland
12
Colombia
12
Burkina Faso
11
Congo, Democratic Republic of
10
Pakistan
10
Benin
9
Argentina
8
Peru
8
East and Southern Africa
8
Albania
7
Haiti
6
South Sudan
6
Germany
6
Syria
6
Tajikistan
6
Georgia
6
Cameroon
5
Thailand
5
Brazil
5
Afghanistan
4
Bolivia
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Venezuela
4
Armenia
4
Southern Africa
4
Guinea
3
Somalia
3
Jordan
3
Lebanon
3
Sudan
3
Sri Lanka
3
Middle East and North Africa
3
Western Pacific Region
3
Paraguay
3
Bhutan
3
Laos
3
Estonia
3
Moldova
3
Iran
3
Vietnam
3
Saudi Arabia
2
Iraq
2
Papua New Guinea
2
North Macedonia
2
Burundi
2
Ecuador
2
El Salvador
2
Yemen
2
Poland
2
Timor Leste/ East Timor
2
Romania
2
North America
2
Uruguay
2
Mali
1
Morocco
1
USA
1
Niger
1
Egypt
1
Gambia
1
Ireland
1
Singapore
1
Central African Republic
1
Hungary
1
Honduras
1
Greece
1
Libya
1
Angola
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Chile
1
Solomon Islands
1
Palestine
1
North Korea
1
Djibouti
1
Mongolia
1
Qatar
1
Bulgaria
1
Gabon
1
Turkmenistan
1
Maldives
1
Tunisia
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1248
Clinical Guidelines
213
Public Health
79
Women & Child Health
70
Key Resources
54
Capacity Building
36
Pharmacy & Technologies
24
Annual Report MEDBOX
1
Toolboxes
TB
517
HIV
445
AMR
100
Pharmacy
59
NTDs
52
COVID-19
47
Mental Health
45
Caregiver
44
Refugee
29
Health Financing Toolbox
26
NCDs
24
Global Health Education
21
Ebola & Marburg
20
Conflict
19
Polio
18
Disability
15
Natural Hazards
11
Malaria
11
Rapid Response
9
Planetary Health
9
Social Ethics
5
Specific Hazards
3
2.0 Rapid Response
3
Cholera
1
South Sudan
1
Zika
1
6th edition, The NLEM 2021 contains 398 drugs molecules in different therapeutic categories.
Best Practice for the Care of Patients with Tuberculosis: a Guide for Low-Income Countries
recommended
2nd edition.
The practical aspects of TB patient care from the onset of symptoms to the completion of treatment are covered in this guide
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati
...
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructur
...
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric o
...
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO
...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant
...
Tuberculosis cases, TB deaths
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB program
...
National Tuberculosis Programme
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality ...
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality ...
Tuberculosis (TB) is among the top ten most common causes of death globally and as a single infectious disease it top among infectious diseases. Furthermore, it is noted as the top causes of death among people infected with the human immunodeficienc
...
Zambia has completed the implementation of the National TB Strategic Plan (2017-2021) that set in motion the TB elimination agenda in Zambia through coordinated and accelerated
...
WHO consolidated guidelines on tuberculosis: Module 6: tuberculosis and comorbidities, 2nd ed
recommended
Addressing TB comorbidities and risk factors is central to the World Health Organization (WHO) End TB Strategy. These guidelines consolidate the latest WHO recommendations on
...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and a
...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
The report explores strategies for sustaining the country’s responses to the three diseases and eventually transitioning away from external funding and programmatic support. It takes stock of Kenya’s health financing landscape and identifies opportunities and challenges for sustaining effective
...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WH
...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and
...
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent
...
